EDGAR Filing Documents for 0001564590-14-005413

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001564590-14-005413

Filing Date

2014-11-10

Accepted

2014-11-10 16:32:32

Documents

Period of Report

2014-09-30

Document Format Files

Seq	Description	Document	Type	Size
1	10-Q	rare-10q_20140930.htm	10-Q	1708885
2	EX-10.1	rare-ex101_20140930241.htm	EX-10.1	37904
3	EX-31.1	rare-ex311_20140930238.htm	EX-31.1	15872
4	EX-31.2	rare-ex312_20140930239.htm	EX-31.2	15947
5	EX-32.1	rare-ex321_20140930240.htm	EX-32.1	10252
6	GRAPHIC	g201411102057504351574.jpg	GRAPHIC	119233
7	GRAPHIC	g201411102057247501875.jpg	GRAPHIC	76877
	Complete submission text file	0001564590-14-005413.txt		7459467

Data Files

Seq	Description	Document	Type	Size
8	XBRL INSTANCE DOCUMENT	rare-20140930.xml	EX-101.INS	1138797
9	XBRL TAXONOMY EXTENSION SCHEMA	rare-20140930.xsd	EX-101.SCH	41969
10	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	rare-20140930_cal.xml	EX-101.CAL	33789
11	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	rare-20140930_def.xml	EX-101.DEF	161218
12	XBRL TAXONOMY EXTENSION LABEL LINKBASE	rare-20140930_lab.xml	EX-101.LAB	298438
13	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	rare-20140930_pre.xml	EX-101.PRE	231549

Mailing Address 60 LEVERONI COURT NOVATO CA 94949

Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800

Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)